DOCCHECK AG (AJ91.DE) Stock Fundamental Analysis
Europe - FRA:AJ91 - DE000A1A6WE6 - Common Stock
12.2 EUR
0 (0%)
AJ91 gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 10 industry peers in the Health Care Technology industry. AJ91 has an excellent financial health rating, but there are some minor concerns on its profitability. AJ91 has a correct valuation and a medium growth rate. AJ91 also has an excellent dividend rating. With these ratings, AJ91 could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
AJ91 had positive earnings in the past year.
In the past year AJ91 had a positive cash flow from operations.
Each year in the past 5 years AJ91 has been profitable.
Each year in the past 5 years AJ91 had a positive operating cash flow.
1.2 Ratios
AJ91 has a better Return On Assets (9.09%) than 80.00% of its industry peers.
With a decent Return On Equity value of 13.18%, AJ91 is doing good in the industry, outperforming 70.00% of the companies in the same industry.
With a Return On Invested Capital value of 8.86%, AJ91 perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
AJ91 had an Average Return On Invested Capital over the past 3 years of 9.31%. This is in line with the industry average of 9.03%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.09% | ||
| ROE | 13.18% | ||
| ROIC | 8.86% |
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
1.3 Margins
AJ91 has a Profit Margin (9.82%) which is comparable to the rest of the industry.
AJ91's Profit Margin has been stable in the last couple of years.
AJ91 has a Operating Margin of 12.33%. This is in the better half of the industry: AJ91 outperforms 70.00% of its industry peers.
AJ91's Operating Margin has declined in the last couple of years.
AJ91 has a Gross Margin of 79.18%. This is comparable to the rest of the industry: AJ91 outperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of AJ91 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.33% | ||
| PM (TTM) | 9.82% | ||
| GM | 79.18% |
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AJ91 is destroying value.
AJ91 has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, AJ91 has more shares outstanding
The debt/assets ratio for AJ91 has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.37 indicates that AJ91 is not in any danger for bankruptcy at the moment.
AJ91 has a better Altman-Z score (4.37) than 80.00% of its industry peers.
There is no outstanding debt for AJ91. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.37 |
ROIC/WACC0.87
WACC10.21%
2.3 Liquidity
A Current Ratio of 2.74 indicates that AJ91 has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.74, AJ91 belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
A Quick Ratio of 2.50 indicates that AJ91 has no problem at all paying its short term obligations.
AJ91's Quick ratio of 2.50 is amongst the best of the industry. AJ91 outperforms 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.74 | ||
| Quick Ratio | 2.5 |
3. Growth
3.1 Past
AJ91 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 133.18%, which is quite impressive.
AJ91 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.57% yearly.
Looking at the last year, AJ91 shows a small growth in Revenue. The Revenue has grown by 0.69% in the last year.
Measured over the past years, AJ91 shows a quite strong growth in Revenue. The Revenue has been growing by 10.68% on average per year.
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 11.73, the valuation of AJ91 can be described as reasonable.
AJ91's Price/Earnings ratio is rather cheap when compared to the industry. AJ91 is cheaper than 90.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.03, AJ91 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.73 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AJ91 indicates a rather cheap valuation: AJ91 is cheaper than 90.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, AJ91 is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.51 | ||
| EV/EBITDA | 3.83 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)1.11
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.05%, AJ91 is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.43, AJ91 pays a better dividend. On top of this AJ91 pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, AJ91 pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.05% |
5.2 History
The dividend of AJ91 has a limited annual growth rate of 4.52%.
Dividend Growth(5Y)4.52%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
AJ91 pays out 48.02% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of AJ91 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.02%
EPS Next 2YN/A
EPS Next 3YN/A
FRA:AJ91 (11/4/2025, 7:00:00 PM)
12.2
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners8.86%
Inst Owner ChangeN/A
Ins Owners71.92%
Ins Owner ChangeN/A
Market Cap61.85M
Revenue(TTM)53.79M
Net Income(TTM)5.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.05% |
Yearly Dividend0.5
Dividend Growth(5Y)4.52%
DP48.02%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.73 | ||
| Fwd PE | N/A | ||
| P/S | 1.15 | ||
| P/FCF | 9.51 | ||
| P/OCF | 8.1 | ||
| P/B | 1.54 | ||
| P/tB | 1.55 | ||
| EV/EBITDA | 3.83 |
EPS(TTM)1.04
EY8.52%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.28
FCFY10.52%
OCF(TTM)1.51
OCFY12.35%
SpS10.61
BVpS7.91
TBVpS7.87
PEG (NY)N/A
PEG (5Y)1.11
Graham Number13.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.09% | ||
| ROE | 13.18% | ||
| ROCE | 14.96% | ||
| ROIC | 8.86% | ||
| ROICexc | 17.58% | ||
| ROICexgc | 17.72% | ||
| OM | 12.33% | ||
| PM (TTM) | 9.82% | ||
| GM | 79.18% | ||
| FCFM | 12.1% |
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
ROICexc(3y)16.17%
ROICexc(5y)32.75%
ROICexgc(3y)16.36%
ROICexgc(5y)34.31%
ROCE(3y)15.72%
ROCE(5y)25.61%
ROICexgc growth 3Y-26.82%
ROICexgc growth 5Y-2.82%
ROICexc growth 3Y-26.26%
ROICexc growth 5Y-1.57%
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
F-Score6
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.88% | ||
| Cap/Sales | 2.11% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.94% | ||
| Profit Quality | 123.15% | ||
| Current Ratio | 2.74 | ||
| Quick Ratio | 2.5 | ||
| Altman-Z | 4.37 |
F-Score6
WACC10.21%
ROIC/WACC0.87
Cap/Depr(3y)102.11%
Cap/Depr(5y)131.26%
Cap/Sales(3y)5.41%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y86.96%
EBIT growth 3Y-26.09%
EBIT growth 5Y7.66%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.74%
FCF growth 3Y-1.99%
FCF growth 5Y54.46%
OCF growth 1Y1.69%
OCF growth 3Y-11.25%
OCF growth 5Y33.53%
DOCCHECK AG / AJ91.DE FAQ
Can you provide the ChartMill fundamental rating for DOCCHECK AG?
ChartMill assigns a fundamental rating of 6 / 10 to AJ91.DE.
Can you provide the valuation status for DOCCHECK AG?
ChartMill assigns a valuation rating of 5 / 10 to DOCCHECK AG (AJ91.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for DOCCHECK AG?
DOCCHECK AG (AJ91.DE) has a profitability rating of 5 / 10.
What is the valuation of DOCCHECK AG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for DOCCHECK AG (AJ91.DE) is 11.73 and the Price/Book (PB) ratio is 1.54.
Can you provide the dividend sustainability for AJ91 stock?
The dividend rating of DOCCHECK AG (AJ91.DE) is 8 / 10 and the dividend payout ratio is 48.02%.